Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA approves 1st-ever gene therapy to restore hearing

Digest more
Top News
Overview
 · 1d · on MSN
FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a cli...

Continue reading

 · 6h
First-ever gene therapy for hearing loss gets FDA approval: 'Groundbreaking'
 · 20h
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program
 · 12h
Regeneron FDA approval: gene therapy for inherited deafness free
The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and Regeneron said it will make the treatment available at no cost to eligible patients...

Continue reading

 · 1d
New Gene Therapy Enables Children With a Rare Form of Deafness to Hear
 · 1d
'A landmark moment for the field': FDA approves first-ever gene therapy for inherited deafness
Forbes
4mon

Gene Editing Or Gene Silencing: The Therapies Poised To Transform Medicine

Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike to confront a pivotal question: should we repair a ...
Nature
4mon

FDA approves first gene therapy from a non-profit organization, but pricing and access questions remain

The FDA has approved Fondazione Telethon ETS’s etuvetidigene autotemcel (Waskyra) for Wiskott–Aldrich syndrome (WAS). Etuvetidigene autotemcel is the first gene therapy to be approved for this rare disease, and Fondazione Telethon is the first non ...
  • Privacy
  • Terms